- Home
- BNR vs GROW Comparison
BNR vs GROW Comparison
Compare BNR & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- GROW
- Stock Information
- Founded
- BNR 2014
- GROW 1968
- Country
- BNR China
- GROW United States
- Employees
- BNR N/A
- GROW N/A
- Industry
- BNR Medical Specialities
- GROW Investment Managers
- Sector
- BNR Health Care
- GROW Finance
- Exchange
- BNR Nasdaq
- GROW Nasdaq
- Market Cap
- BNR 38.3M
- GROW 31.8M
- IPO Year
- BNR 2020
- GROW N/A
- Fundamental
- Price
- BNR $6.13
- GROW $2.42
- Analyst Decision
- BNR
- GROW
- Analyst Count
- BNR 0
- GROW 0
- Target Price
- BNR N/A
- GROW N/A
- AVG Volume (30 Days)
- BNR 53.5K
- GROW 38.8K
- Earning Date
- BNR 08-21-2025
- GROW 09-09-2025
- Dividend Yield
- BNR N/A
- GROW 3.67%
- EPS Growth
- BNR N/A
- GROW N/A
- EPS
- BNR N/A
- GROW 0.01
- Revenue
- BNR $72,112,038.00
- GROW $8,932,000.00
- Revenue This Year
- BNR $136.32
- GROW N/A
- Revenue Next Year
- BNR N/A
- GROW N/A
- P/E Ratio
- BNR N/A
- GROW $233.35
- Revenue Growth
- BNR 0.53
- GROW N/A
- 52 Week Low
- BNR $2.18
- GROW $2.02
- 52 Week High
- BNR $9.48
- GROW $2.69
- Technical
- Relative Strength Index (RSI)
- BNR 56.55
- GROW 51.48
- Support Level
- BNR $6.71
- GROW $2.43
- Resistance Level
- BNR $9.48
- GROW $2.58
- Average True Range (ATR)
- BNR 0.85
- GROW 0.07
- MACD
- BNR 0.17
- GROW -0.01
- Stochastic Oscillator
- BNR 34.46
- GROW 43.48
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.